Dry Eye Disease Market: Industry Analysis and forecast (2019 to 2027): By Product, Distribution Channel, Treatment, and Region

Dry Eye Disease Market was valued US$ XX Bn in 2018 and is expected to reach US$ XX Bn by 2027, at CAGR of XX% during forecast period of 2019 to 2027. To know about the Research Methodology :- Request Free Sample Report Dry eye disease is also known as Keratoconjunctivitis sicca is a common condition which can be cured by treatment. Dry eye syndrome is an ocular disorder caused by the absence of tear fluid to lubricate the eyes. Dry eye disease is one of the most common eye disorders around the world and is particularly common in the elderly demographic.The report study has analyzed revenue impact of COVID -19 pandemic on the sales revenue of market leaders, market followers and market disrupters in the report and same is reflected in our analysis.

Dry Eye Disease Market Drivers and Restrains

Common factors responsible for Dry Eye Disease, such as aging, systemic inflammatory diseases, decrease in the supportive hormones, ocular surface diseases, or surgeries that affect the cholinergic nerves, which stimulate tear secretion. They may be associated with the increasing dry eye-related diseases. The global dry eye diseases market has also been boost up by the increasing awareness among the population about this disease. Dry eye diseases is ignored by many patients, since the troublesomeness caused by it is not debilitating. But, the increasing awareness about the diagnosis and treatment of the disease has resulted in more patients proactively trying to cure the syndrome, driving the global dry eye syndrome market. Stable government support for medical research has permitted researchers to treat this condition more comprehensively and precisely. Productive research in current year, which is helping the global dry eye disease market to post a high growth rate. The popularity of self-medication by patients, High cost and limited availability of effective therapeutics remains a main restraint on the dry eye syndrome market at present. Furthermore, the expiration of patents on major drugs used in the treatment of dry eye syndrome is a major restraint on the global dry eye syndrome market. Manufacturers in the Dry Eye Disease are focusing on competitive pricing as the strategy to capture significant market share. Moreover, strategic mergers and acquisitions and technological innovations are also the key focus areas of the manufacturers.

Dry Eye Disease Market Segmentation Analysis

In terms of segmental analysis Dry Eye Disease Market is segmented into Product type, Distribution Channel, Treatment, and Region. Based on the type, dry eye syndrome treatment market is divided into aqueous dry eye syndrome and evaporative dry eye syndrome. In terms of Product market is segmented into Artificial Tears, Anti-inflammatory Drugs, Punctal Plugs and Secretagogue. According to the ARVO journal, evaporative dry eye disease is more common as compared to aqueous dry eye disease. On the basis of the treatment, the market is segmented into cyclosporine, corticosteroids, artificial tears, and punctual bags. According to the NCBI, among dry eye patients over 65 years of age XX% apply artificial tears and XX % of them stayed eye care professionals before starting any medications. Furthermore, on the basis of distribution channels, the market is segmented as online pharmacies, hospital pharmacies, and retail pharmacies.

Dry Eye Disease Market Regional Analysis

On the basis of region Dry Eye Disease Market divided into five region such as Asia Pacific, North America, Europe, Latin America, and Middle East Africa. Among all the regions, North America had hold the largest market share in 2018 and is projected to lead the market during the forecast period. Because of presence of key market players associated with the dry eye syndrome treatments and huge patient population. According to, America Journal of Ophthalmology, more than XX million U.S. adults are treatment with dry eye disease. The high occurrence of lifestyle disorders that rise the chances of contracting dry eye disease in this region is a major driver factor for the North America. Medicines like pain relievers, antihistamines, and antidepressants, which is proliferating in North America, also reportedly growth the risk of dry eye syndrome. Asia Pacific is expected to be the second largest market over the forecast period and nearly follow by North America in terms of profits. The objective of the report is to present comprehensive analysis of Dry Eye Disease Market including all the stakeholders of the industry. The past and current status of the industry with forecasted market size and trends are presented in the report with the analysis of complicated data in simple language. The report covers all the aspects of industry with dedicated study of key players that includes market leaders, followers and new entrants by region. PORTER, SVOR, PESTEL analysis with the potential impact of micro-economic factors by region on the market have been presented in the report. External as well as internal factors that are supposed to affect the business positively or negatively have been analyzed, which will give clear futuristic view of the industry to the decision makers. The report also helps in understanding Dry Eye Disease Market dynamics, structure by analyzing the market segments, and project the Dry Eye Disease Market size. Clear representation of competitive analysis of key players by Dry Eye Disease Type, price, financial position, product portfolio, growth strategies, and regional presence in the Dry Eye Disease Market make the report investor’s guide.

Scope of the Dry Eye Disease Market: Inquire before buying

Dry Eye Disease Market, by Product

• Artificial Tears • Anti-inflammatory Drugs • Punctal Plugs • Secretagogue

Dry Eye Disease Market, by Distribution Channel

• Hospital Pharmacies • Independent Pharmacies and Drug Stores • Online Pharmacies

Dry Eye Disease Market, by Type

• Evaporative Dry • Aqueous Dry

Dry Eye Disease Market, by Treatment

• Cyclosporine • Corticosteroids • Lubricant Eye drops • Punctual Bags • Artificial Tears • Drugs

Dry Eye Disease Market, by Region

• Asia Pacific • North America • Europe • Latin America • Middle East Africa

Dry Eye Disease Market, Major Players

• Novartis AG (Alcon) • ALLERGAN • Johnson & Johnson • Vision Care • Otsuka Pharmaceutical Vo. Ltd. • Shire • OASIS Medical • Santen Pharmaceutical Co. Ltd. • AFT Pharmaceuticals • I-Med Pharma Inc. • Sentiss Pharma Pvt. Ltd. • Scope Ophthalmics Ltd. • Sanofi Pasteur • Serum Institute • Bavarian Nordic • CSL Ltd. • Emergent Biosolutions, Inc. • F. Hoffmann-La Roche Ltd. • Gilead Sciences • Inovio Pharmaceuticals • Novavax, Inc. • SELLAS Life Sciences Group, Inc
Dry Eye Disease Market 1. Preface 1.1. Report Scope and Market Segmentation 1.2. Research Highlights 1.3. Research Objectives 2. Assumptions and Research Methodology 2.1. Report Assumptions 2.2. Abbreviations 2.3. Research Methodology 2.3.1. Secondary Research 2.3.1.1. Secondary data 2.3.1.2. Secondary Sources 2.3.2. Primary Research 2.3.2.1. Data from Primary Sources 2.3.2.2. Breakdown of Primary Sources 3. Executive Summary: Dry Eye Disease Market Size, by Market Value (US$ Bn) and Market Volume (Units) 4. Market Overview 4.1. Introduction 4.2. Market Indicator 4.2.1. Drivers 4.2.2. Restraints 4.2.3. Opportunities 4.2.4. Challenges 4.3. Porter’s Analysis 4.4. Value Chain Analysis 4.5. Market Risk Analysis 4.6. SWOT Analysis 4.7. Industry Trends and Emerging Technologies 5. Supply Side and Demand Side Indicators 6. Dry Eye Disease Market Analysis and Forecast 6.1. Dry Eye Disease Market Size & Y-o-Y Growth Analysis 6.1.1. North America 6.1.2. Europe 6.1.3. Asia Pacific 6.1.4. Middle East & Africa 6.1.5. South America 7. Dry Eye Disease Market Analysis and Forecast, by Product 7.1. Introduction and Definition 7.2. Key Findings 7.3. Dry Eye Disease Market Value Share Analysis, by Product 7.4. Dry Eye Disease Market Size (US$ Bn) Forecast, by Product 7.5. Dry Eye Disease Market Analysis, by Product 7.6. Dry Eye Disease Market Attractiveness Analysis, by Product 8. Dry Eye Disease Market Analysis and Forecast, by Type 8.1. Introduction and Definition 8.2. Key Findings 8.3. Dry Eye Disease Market Value Share Analysis, by Type 8.4. Dry Eye Disease Market Size (US$ Bn) Forecast, by Type 8.5. Dry Eye Disease Market Analysis, by Type 8.6. Dry Eye Disease Market Attractiveness Analysis, by Type 9. Dry Eye Disease Market Analysis and Forecast, by Distribution Channel 9.1. Introduction and Definition 9.2. Key Findings 9.3. Dry Eye Disease Market Value Share Analysis, by Distribution Channel 9.4. Dry Eye Disease Market Size (US$ Bn) Forecast, by Distribution Channel 9.5. Dry Eye Disease Market Analysis, by Distribution Channel 9.6. Dry Eye Disease Market Attractiveness Analysis, by Distribution Channel 10. Dry Eye Disease Market Analysis and Forecast, by Treatment 10.1. Introduction and Definition 10.2. Key Findings 10.3. Dry Eye Disease Market Value Share Analysis, by Treatment 10.4. Dry Eye Disease Market Size (US$ Bn) Forecast, by Treatment 10.5. Dry Eye Disease Market Analysis, by Treatment 10.6. Dry Eye Disease Market Attractiveness Analysis, by Treatment 11. Dry Eye Disease Market Analysis, by Region 11.1. Dry Eye Disease Market Value Share Analysis, by Region 11.2. Dry Eye Disease Market Size (US$ Bn) Forecast, by Region 11.3. Dry Eye Disease Market Attractiveness Analysis, by Region 12. North America Dry Eye Disease Market Analysis 12.1. Key Findings 12.2. North America Dry Eye Disease Market Overview 12.3. North America Dry Eye Disease Market Value Share Analysis, by Product 12.4. North America Dry Eye Disease Market Forecast, by Product 12.4.1. Artificial Tears 12.4.2. Anti-inflammatory Drugs 12.4.3. Punctal Plugs 12.4.4. Secretagogue 12.5. North America Dry Eye Disease Market Value Share Analysis, by Type 12.6. North America Dry Eye Disease Market Forecast, by Type 12.6.1. Evaporative Dry 12.6.2. Aqueous Dry 12.7. North America Dry Eye Disease Market Value Share Analysis, by Distribution Channel 12.8. North America Dry Eye Disease Market Forecast, by Distribution Channel 12.8.1. Hospital Pharmacies 12.8.2. Independent Pharmacies and Drug Stores 12.8.3. Online Pharmacies 12.9. North America Dry Eye Disease Market Value Share Analysis, by Treatment 12.10. North America Dry Eye Disease Market Forecast, by Treatment 12.10.1.1. Lubricant Eye drops 12.10.1.2. Punctual Bags 12.10.1.3. Artificial Tears 12.10.1.4. Drugs 12.11. North America Dry Eye Disease Market Value Share Analysis, by Country 12.12. North America Dry Eye Disease Market Forecast, by Country 12.12.1. U.S. 12.12.2. Canada 12.13. North America Dry Eye Disease Market Analysis, by Country 12.14. U.S. Dry Eye Disease Market Forecast, by Product 12.14.1. Artificial Tears 12.14.2. Anti-inflammatory Drugs 12.14.3. Punctal Plugs 12.14.4. Secretagogue 12.15. U.S. Dry Eye Disease Market Forecast, by Type 12.15.1. Evaporative Dry 12.15.2. Aqueous Dry 12.16. U.S. Dry Eye Disease Market Forecast, by Distribution Channel 12.16.1. Hospital Pharmacies 12.16.2. Independent Pharmacies and Drug Stores 12.16.3. Online Pharmacies 12.17. U.S. Dry Eye Disease Market Forecast, by Treatment 12.17.1.1. Lubricant Eye drops 12.17.1.2. Punctual Bags 12.17.1.3. Artificial Tears 12.17.1.4. Drugs 12.18. Canada Dry Eye Disease Market Forecast, by Product 12.18.1. Artificial Tears 12.18.2. Anti-inflammatory Drugs 12.18.3. Punctal Plugs 12.18.4. Secretagogue 12.19. Canada Dry Eye Disease Market Forecast, by Type 12.19.1. Evaporative Dry 12.19.2. Aqueous Dry 12.20. Canada Dry Eye Disease Market Forecast, by Distribution Channel 12.20.1. Hospital Pharmacies 12.20.2. Independent Pharmacies and Drug Stores 12.20.3. Online Pharmacies 12.21. Canada Dry Eye Disease Market Forecast, by Treatment 12.21.1.1. Lubricant Eye drops 12.21.1.2. Punctual Bags 12.21.1.3. Artificial Tears 12.21.1.4. Drugs 12.22. North America Dry Eye Disease Market Attractiveness Analysis 12.22.1. By Product 12.22.2. By Type 12.22.3. By Distribution Channel 12.22.4. By Treatment 12.23. PEST Analysis 12.24. Key Trends 12.25. Key Developments 13. Europe Dry Eye Disease Market Analysis 13.1. Key Findings 13.2. Europe Dry Eye Disease Market Overview 13.3. Europe Dry Eye Disease Market Value Share Analysis, by Product 13.4. Europe Dry Eye Disease Market Forecast, by Product 13.4.1. Artificial Tears 13.4.2. Anti-inflammatory Drugs 13.4.3. Punctal Plugs 13.4.4. Secretagogue 13.5. Europe Dry Eye Disease Market Value Share Analysis, by Type 13.6. Europe Dry Eye Disease Market Forecast, by Type 13.6.1. Evaporative Dry 13.6.2. Aqueous Dry 13.7. Europe Dry Eye Disease Market Value Share Analysis, by Distribution Channel 13.8. Europe Dry Eye Disease Market Forecast, by Distribution Channel 13.8.1. Hospital Pharmacies 13.8.2. Independent Pharmacies and Drug Stores 13.8.3. Online Pharmacies 13.9. Europe Dry Eye Disease Market Value Share Analysis, by Treatment 13.10. Europe Dry Eye Disease Market Forecast, by Treatment 13.10.1.1. Lubricant Eye drops 13.10.1.2. Punctual Bags 13.10.1.3. Artificial Tears 13.10.1.4. Drugs 13.11. Europe Dry Eye Disease Market Value Share Analysis, by Country 13.12. Europe Dry Eye Disease Market Forecast, by Country 13.12.1. Germany 13.12.2. U.K. 13.12.3. France 13.12.4. Italy 13.12.5. Spain 13.12.6. Rest of Europe 13.13. Europe Dry Eye Disease Market Analysis, by Country 13.14. Germany Dry Eye Disease Market Forecast, by Product 13.14.1. Artificial Tears 13.14.2. Anti-inflammatory Drugs 13.14.3. Punctal Plugs 13.14.4. Secretagogue 13.15. Germany Dry Eye Disease Market Forecast, by Type 13.15.1. Evaporative Dry 13.15.2. Aqueous Dry 13.16. Germany Dry Eye Disease Market Forecast, by Distribution Channel 13.16.1. Hospital Pharmacies 13.16.2. Independent Pharmacies and Drug Stores 13.16.3. Online Pharmacies 13.17. Germany Dry Eye Disease Market Forecast, by Treatment 13.17.1.1. Lubricant Eye drops 13.17.1.2. Punctual Bags 13.17.1.3. Artificial Tears 13.17.1.4. Drugs 13.18. U.K. Dry Eye Disease Market Forecast, by Product 13.18.1. Artificial Tears 13.18.2. Anti-inflammatory Drugs 13.18.3. Punctal Plugs 13.18.4. Secretagogue 13.19. U.K. Dry Eye Disease Market Forecast, by Type 13.19.1. Evaporative Dry 13.19.2. Aqueous Dry 13.20. U.K. Dry Eye Disease Market Forecast, by Distribution Channel 13.20.1. Hospital Pharmacies 13.20.2. Independent Pharmacies and Drug Stores 13.20.3. Online Pharmacies 13.21. U.K. Dry Eye Disease Market Forecast, by Treatment 13.21.1.1. Lubricant Eye drops 13.21.1.2. Punctual Bags 13.21.1.3. Artificial Tears 13.21.1.4. Drugs 13.22. France Dry Eye Disease Market Forecast, by Product 13.22.1. Artificial Tears 13.22.2. Anti-inflammatory Drugs 13.22.3. Punctal Plugs 13.22.4. Secretagogue 13.23. France Dry Eye Disease Market Forecast, by Type 13.23.1. Evaporative Dry 13.23.2. Aqueous Dry 13.24. France Dry Eye Disease Market Forecast, by Distribution Channel 13.24.1. Hospital Pharmacies 13.24.2. Independent Pharmacies and Drug Stores 13.24.3. Online Pharmacies 13.25. France Dry Eye Disease Market Forecast, by Treatment 13.25.1.1. Lubricant Eye drops 13.25.1.2. Punctual Bags 13.25.1.3. Artificial Tears 13.25.1.4. Drugs 13.26. Italy Dry Eye Disease Market Forecast, by Product 13.26.1. Artificial Tears 13.26.2. Anti-inflammatory Drugs 13.26.3. Punctal Plugs 13.26.4. Secretagogue 13.27. Italy Dry Eye Disease Market Forecast, by Type 13.27.1. Evaporative Dry 13.27.2. Aqueous Dry 13.28. Italy Dry Eye Disease Market Forecast, by Distribution Channel 13.28.1. Hospital Pharmacies 13.28.2. Independent Pharmacies and Drug Stores 13.28.3. Online Pharmacies 13.29. Italy Dry Eye Disease Market Forecast, by Treatment 13.29.1.1. Lubricant Eye drops 13.29.1.2. Punctual Bags 13.29.1.3. Artificial Tears 13.29.1.4. Drugs 13.30. Spain Dry Eye Disease Market Forecast, by Product 13.30.1. Artificial Tears 13.30.2. Anti-inflammatory Drugs 13.30.3. Punctal Plugs 13.30.4. Secretagogue 13.31. Spain Dry Eye Disease Market Forecast, by Type 13.31.1. Evaporative Dry 13.31.2. Aqueous Dry 13.32. Spain Dry Eye Disease Market Forecast, by Distribution Channel 13.32.1. Hospital Pharmacies 13.32.2. Independent Pharmacies and Drug Stores 13.32.3. Online Pharmacies 13.33. Spain Dry Eye Disease Market Forecast, by Treatment 13.33.1.1. Lubricant Eye drops 13.33.1.2. Punctual Bags 13.33.1.3. Artificial Tears 13.33.1.4. Drugs 13.34. Rest of Europe Dry Eye Disease Market Forecast, by Product 13.34.1. Artificial Tears 13.34.2. Anti-inflammatory Drugs 13.34.3. Punctal Plugs 13.34.4. Secretagogue 13.35. Rest of Europe Dry Eye Disease Market Forecast, by Type 13.35.1. Evaporative Dry 13.35.2. Aqueous Dry 13.36. Rest of Europe Dry Eye Disease Market Forecast, by Distribution Channel 13.36.1. Hospital Pharmacies 13.36.2. Independent Pharmacies and Drug Stores 13.36.3. Online Pharmacies 13.37. Rest Of Europe Dry Eye Disease Market Forecast, by Treatment 13.37.1.1. Lubricant Eye drops 13.37.1.2. Punctual Bags 13.37.1.3. Artificial Tears 13.37.1.4. Drugs 13.38. Europe Dry Eye Disease Market Attractiveness Analysis 13.38.1. By Product 13.38.2. By Type 13.38.3. By Distribution Channel 13.38.4. By Treatment 13.39. PEST Analysis 13.40. Key Trends 13.41. Key Developments 14. Asia Pacific Dry Eye Disease Market Analysis 14.1. Key Findings 14.2. Asia Pacific Dry Eye Disease Market Overview 14.3. Asia Pacific Dry Eye Disease Market Value Share Analysis, by Product 14.4. Asia Pacific Dry Eye Disease Market Forecast, by Product 14.4.1. Artificial Tears 14.4.2. Anti-inflammatory Drugs 14.4.3. Punctal Plugs 14.4.4. Secretagogue 14.5. Asia Pacific Dry Eye Disease Market Value Share Analysis, by Type 14.6. Asia Pacific Dry Eye Disease Market Forecast, by Type 14.6.1. Evaporative Dry 14.6.2. Aqueous Dry 14.7. Asia Pacific Dry Eye Disease Market Value Share Analysis, by Distribution Channel 14.8. Asia Pacific Dry Eye Disease Market Forecast, by Distribution Channel 14.8.1. Hospital Pharmacies 14.8.2. Independent Pharmacies and Drug Stores 14.8.3. Online Pharmacies 14.9. Asia Pacific Dry Eye Disease Market Value Share Analysis, by Treatment 14.10. Asia Pacific Dry Eye Disease Market Forecast, by Treatment 14.10.1.1. Lubricant Eye drops 14.10.1.2. Punctual Bags 14.10.1.3. Artificial Tears 14.10.1.4. Drugs 14.11. Asia Pacific Dry Eye Disease Market Value Share Analysis, by Country 14.12. Asia Pacific Dry Eye Disease Market Forecast, by Country 14.12.1. China 14.12.2. India 14.12.3. Japan 14.12.4. ASEAN 14.12.5. Rest of Asia Pacific 14.13. Asia Pacific Dry Eye Disease Market Analysis, by Country 14.14. China Dry Eye Disease Market Forecast, by Product 14.14.1. Artificial Tears 14.14.2. Anti-inflammatory Drugs 14.14.3. Punctal Plugs 14.14.4. Secretagogue 14.15. China Dry Eye Disease Market Forecast, by Type 14.15.1. Evaporative Dry 14.15.2. Aqueous Dry 14.16. China Dry Eye Disease Market Forecast, by Distribution Channel 14.16.1. Hospital Pharmacies 14.16.2. Independent Pharmacies and Drug Stores 14.16.3. Online Pharmacies 14.17. China Dry Eye Disease Market Forecast, by Treatment 14.17.1.1. Lubricant Eye drops 14.17.1.2. Punctual Bags 14.17.1.3. Artificial Tears 14.17.1.4. Drugs 14.18. India Dry Eye Disease Market Forecast, by Product 14.18.1. Artificial Tears 14.18.2. Anti-inflammatory Drugs 14.18.3. Punctal Plugs 14.18.4. Secretagogue 14.19. India Dry Eye Disease Market Forecast, by Type 14.19.1. Evaporative Dry 14.19.2. Aqueous Dry 14.20. India Dry Eye Disease Market Forecast, by Distribution Channel 14.20.1. Hospital Pharmacies 14.20.2. Independent Pharmacies and Drug Stores 14.20.3. Online Pharmacies 14.21. India Dry Eye Disease Market Forecast, by Treatment 14.21.1.1. Lubricant Eye drops 14.21.1.2. Punctual Bags 14.21.1.3. Artificial Tears 14.21.1.4. Drugs 14.22. Japan Dry Eye Disease Market Forecast, by Product 14.22.1. Artificial Tears 14.22.2. Anti-inflammatory Drugs 14.22.3. Punctal Plugs 14.22.4. Secretagogue 14.23. Japan Dry Eye Disease Market Forecast, by Type 14.23.1. Evaporative Dry 14.23.2. Aqueous Dry 14.24. Japan Dry Eye Disease Market Forecast, by Distribution Channel 14.24.1. Hospital Pharmacies 14.24.2. Independent Pharmacies and Drug Stores 14.24.3. Online Pharmacies 14.25. Japan Dry Eye Disease Market Forecast, by Treatment 14.25.1.1. Lubricant Eye drops 14.25.1.2. Punctual Bags 14.25.1.3. Artificial Tears 14.25.1.4. Drugs 14.26. ASEAN Dry Eye Disease Market Forecast, by Product 14.26.1. Artificial Tears 14.26.2. Anti-inflammatory Drugs 14.26.3. Punctal Plugs 14.26.4. Secretagogue 14.27. ASEAN Dry Eye Disease Market Forecast, by Type 14.27.1. Evaporative Dry 14.27.2. Aqueous Dry 14.28. ASEAN Dry Eye Disease Market Forecast, by Distribution Channel 14.28.1. Hospital Pharmacies 14.28.2. Independent Pharmacies and Drug Stores 14.28.3. Online Pharmacies 14.29. ASEAN Dry Eye Disease Market Forecast, by Treatment 14.29.1.1. Lubricant Eye drops 14.29.1.2. Punctual Bags 14.29.1.3. Artificial Tears 14.29.1.4. Drugs 14.30. Rest of Asia Pacific Dry Eye Disease Market Forecast, by Product 14.30.1. Artificial Tears 14.30.2. Anti-inflammatory Drugs 14.30.3. Punctal Plugs 14.30.4. Secretagogue 14.31. Rest of Asia Pacific Dry Eye Disease Market Forecast, by Type 14.31.1. Evaporative Dry 14.31.2. Aqueous Dry 14.32. Rest of Asia Pacific Dry Eye Disease Market Forecast, by Distribution Channel 14.32.1. Hospital Pharmacies 14.32.2. Independent Pharmacies and Drug Stores 14.32.3. Online Pharmacies 14.33. Rest of Asia Pacific Dry Eye Disease Market Forecast, by Treatment 14.33.1.1. Lubricant Eye drops 14.33.1.2. Punctual Bags 14.33.1.3. Artificial Tears 14.33.1.4. Drugs 14.34. Asia Pacific Dry Eye Disease Market Attractiveness Analysis 14.34.1. By Product 14.34.2. By Type 14.34.3. By Distribution Channel 14.34.4. By Treatment 14.35. PEST Analysis 14.36. Key Trends 14.37. Key Developments 15. Middle East & Africa Dry Eye Disease Market Analysis 15.1. Key Findings 15.2. Middle East & Africa Dry Eye Disease Market Overview 15.3. Middle East & Africa Dry Eye Disease Market Value Share Analysis, by Product 15.4. Middle East & Africa Dry Eye Disease Market Forecast, by Product 15.4.1. Artificial Tears 15.4.2. Anti-inflammatory Drugs 15.4.3. Punctal Plugs 15.4.4. Secretagogue 15.5. Middle East & Africa Dry Eye Disease Market Value Share Analysis, by Type 15.6. Middle East & Africa Dry Eye Disease Market Forecast, by Type 15.6.1. Evaporative Dry 15.6.2. Aqueous Dry 15.7. Middle East & Africa Dry Eye Disease Market Value Share Analysis, by Distribution Channel 15.8. Middle East & Africa Dry Eye Disease Market Forecast, by Distribution Channel 15.8.1. Hospital Pharmacies 15.8.2. Independent Pharmacies and Drug Stores 15.8.3. Online Pharmacies 15.9. Middle East & Africa Dry Eye Disease Market Value Share Analysis, by Treatment 15.10. Middle East & Africa Dry Eye Disease Market Forecast, by Treatment 15.10.1.1. Lubricant Eye drops 15.10.1.2. Punctual Bags 15.10.1.3. Artificial Tears 15.10.1.4. Drugs 15.11. Middle East & Africa Dry Eye Disease Market Value Share Analysis, by Country 15.12. Middle East & Africa Dry Eye Disease Market Forecast, by Country 15.12.1. GCC 15.12.2. South Africa 15.12.3. Rest of Middle East & Africa 15.13. Middle East & Africa Dry Eye Disease Market Analysis, by Country 15.14. GCC Dry Eye Disease Market Forecast, by Product 15.14.1. Artificial Tears 15.14.2. Anti-inflammatory Drugs 15.14.3. Punctal Plugs 15.14.4. Secretagogue 15.15. GCC Dry Eye Disease Market Forecast, by Type 15.15.1. Evaporative Dry 15.15.2. Aqueous Dry 15.16. GCC Dry Eye Disease Market Forecast, by Distribution Channel 15.16.1. Hospital Pharmacies 15.16.2. Independent Pharmacies and Drug Stores 15.16.3. Online Pharmacies 15.17. GCC Dry Eye Disease Market Forecast, by Treatment 15.17.1.1. Lubricant Eye drops 15.17.1.2. Punctual Bags 15.17.1.3. Artificial Tears 15.17.1.4. Drugs 15.18. South Africa Dry Eye Disease Market Forecast, by Product 15.18.1. Artificial Tears 15.18.2. Anti-inflammatory Drugs 15.18.3. Punctal Plugs 15.18.4. Secretagogue 15.19. South Africa Dry Eye Disease Market Forecast, by Type 15.19.1. Evaporative Dry 15.19.2. Aqueous Dry 15.20. South Africa Dry Eye Disease Market Forecast, by Distribution Channel 15.20.1. Hospital Pharmacies 15.20.2. Independent Pharmacies and Drug Stores 15.20.3. Online Pharmacies 15.21. South Africa Dry Eye Disease Market Forecast, by Treatment 15.21.1.1. Lubricant Eye drops 15.21.1.2. Punctual Bags 15.21.1.3. Artificial Tears 15.21.1.4. Drugs 15.22. Rest of Middle East & Africa Dry Eye Disease Market Forecast, by Product 15.22.1. Artificial Tears 15.22.2. Anti-inflammatory Drugs 15.22.3. Punctal Plugs 15.22.4. Secretagogue 15.23. Rest of Middle East & Africa Dry Eye Disease Market Forecast, by Type 15.23.1. Evaporative Dry 15.23.2. Aqueous Dry 15.24. Rest of Middle East & Africa Dry Eye Disease Market Forecast, by Distribution Channel 15.24.1. Hospital Pharmacies 15.24.2. Independent Pharmacies and Drug Stores 15.24.3. Online Pharmacies 15.25. Rest of Middle East & Africa Dry Eye Disease Market Forecast, by Treatment 15.25.1.1. Lubricant Eye drops 15.25.1.2. Punctual Bags 15.25.1.3. Artificial Tears 15.25.1.4. Drugs 15.26. Middle East & Africa Dry Eye Disease Market Attractiveness Analysis 15.26.1. By Product 15.26.2. By Type 15.26.3. By Distribution Channel 15.26.4. By Treatment 15.27. PEST Analysis 15.28. Key Trends 15.29. Key Developments 16. South America Dry Eye Disease Market Analysis 16.1. Key Findings 16.2. South America Dry Eye Disease Market Overview 16.3. South America Dry Eye Disease Market Value Share Analysis, by Product 16.4. South America Dry Eye Disease Market Forecast, by Product 16.4.1. Artificial Tears 16.4.2. Anti-inflammatory Drugs 16.4.3. Punctal Plugs 16.4.4. Secretagogue 16.5. South America Dry Eye Disease Market Value Share Analysis, by Type 16.6. South America Dry Eye Disease Market Forecast, by Type 16.6.1. Evaporative Dry 16.6.2. Aqueous Dry 16.7. South America Dry Eye Disease Market Value Share Analysis, by Distribution Channel 16.8. South America Dry Eye Disease Market Forecast, by Distribution Channel 16.8.1. Hospital Pharmacies 16.8.2. Independent Pharmacies and Drug Stores 16.8.3. Online Pharmacies 16.9. South America Dry Eye Disease Market Value Share Analysis, by Treatment 16.10. South America Dry Eye Disease Market Forecast, by Treatment 16.10.1.1. Lubricant Eye drops 16.10.1.2. Punctual Bags 16.10.1.3. Artificial Tears 16.10.1.4. Drugs 16.11. South America Dry Eye Disease Market Value Share Analysis, by Country 16.12. South America Dry Eye Disease Market Forecast, by Country 16.12.1. Brazil 16.12.2. Mexico 16.12.3. Rest of South America 16.13. South America Dry Eye Disease Market Analysis, by Country 16.14. Brazil Dry Eye Disease Market Forecast, by Product 16.14.1. Artificial Tears 16.14.2. Anti-inflammatory Drugs 16.14.3. Punctal Plugs 16.14.4. Secretagogue 16.15. Brazil Dry Eye Disease Market Forecast, by Type 16.15.1. Evaporative Dry 16.15.2. Aqueous Dry 16.16. Brazil Dry Eye Disease Market Forecast, by Distribution Channel 16.16.1. Hospital Pharmacies 16.16.2. Independent Pharmacies and Drug Stores 16.16.3. Online Pharmacies 16.17. Brazil Dry Eye Disease Market Forecast, by Treatment 16.17.1.1. Lubricant Eye drops 16.17.1.2. Punctual Bags 16.17.1.3. Artificial Tears 16.17.1.4. Drugs 16.18. Mexico Dry Eye Disease Market Forecast, by Product 16.18.1. Artificial Tears 16.18.2. Anti-inflammatory Drugs 16.18.3. Punctal Plugs 16.18.4. Secretagogue 16.19. Mexico Dry Eye Disease Market Forecast, by Type 16.19.1. Evaporative Dry 16.19.2. Aqueous Dry 16.20. Mexico Dry Eye Disease Market Forecast, by Distribution Channel 16.20.1. Hospital Pharmacies 16.20.2. Independent Pharmacies and Drug Stores 16.20.3. Online Pharmacies 16.21. Mexico Dry Eye Disease Market Forecast, by Treatment 16.21.1.1. Lubricant Eye drops 16.21.1.2. Punctual Bags 16.21.1.3. Artificial Tears 16.21.1.4. Drugs 16.22. Rest of South America Dry Eye Disease Market Forecast, by Product 16.22.1. Artificial Tears 16.22.2. Anti-inflammatory Drugs 16.22.3. Punctal Plugs 16.22.4. Secretagogue 16.23. Rest of South America Dry Eye Disease Market Forecast, by Type 16.23.1. Evaporative Dry 16.23.2. Aqueous Dry 16.24. Rest of South America Dry Eye Disease Market Forecast, by Distribution Channel 16.24.1. Hospital Pharmacies 16.24.2. Independent Pharmacies and Drug Stores 16.24.3. Online Pharmacies 16.25. Rest of South America Dry Eye Disease Market Forecast, by Treatment 16.25.1.1. Lubricant Eye drops 16.25.1.2. Punctual Bags 16.25.1.3. Artificial Tears 16.25.1.4. Drugs Punctual Bags 16.25.1.5. Artificial Tears 16.25.1.6. Drugs 16.26. South America Dry Eye Disease Market Attractiveness Analysis 16.26.1. By Product 16.26.2. By Type 16.26.3. By Distribution Channel 16.26.4. By Treatment 16.27. PEST Analysis 16.28. Key Trends 16.29. Key Developments 17. Company Profiles 17.1. Market Share Analysis, by Company 17.2. Competition Matrix 17.2.1. Competitive Benchmarking of key players by price, presence, market share, Applications and R&D investment 17.2.2. New Product Launches and Product Enhancements 17.2.3. Market Consolidation 17.2.3.1. M&A by Regions, Investment and Applications 17.2.3.2. M&A Key Players, Forward Integration and Backward Integration 17.3. Company Profiles: Key Players 17.3.1. Novartis AG (Alcon) 17.3.1.1. Company Overview 17.3.1.2. Financial Overview 17.3.1.3. Product Portfolio 17.3.1.4. Business Strategy 17.3.1.5. Recent Developments 17.3.1.6. Company Footprint 17.3.2. ALLERGAN 17.3.3. Johnson & Johnson 17.3.4. Vision Care 17.3.5. Otsuka Pharmaceutical Vo. Ltd. 17.3.6. Shire 17.3.7. OASIS Medical 17.3.8. Santen Pharmaceutical Co. Ltd. 17.3.9. AFT Pharmaceuticals 17.3.10. I-Med Pharma Inc. 17.3.11. Sentiss Pharma Pvt. Ltd. 17.3.12. Scope Ophthalmics Ltd. 17.3.13. Sanofi Pasteur 17.3.14. Serum Institute 17.3.15. Bavarian Nordic 17.3.16. CSL Ltd. 17.3.17. Emergent Biosolutions, Inc. 17.3.18. F. Hoffmann-La Roche Ltd. 17.3.19. Gilead Sciences 17.3.20. Inovio Pharmaceuticals 17.3.21. Novavax, Inc. 17.3.22. SELLAS Life Sciences Group, Inc 18. Primary Key Insights

About This Report

Report ID36619
Category Healthcare
Published DateNov 2019
Updated DateNov 2020
Contact Us